• Title/Summary/Keyword: Sustained release

Search Result 352, Processing Time 0.029 seconds

Controlled Release and Bioavailability of Piracetam (피라세탐의 방출조절 및 생체이용률)

  • Kang, Chin-Yang;Lee, Kyung-Tae;Seo, Seong-Hoon
    • Journal of Pharmaceutical Investigation
    • /
    • v.28 no.2
    • /
    • pp.109-113
    • /
    • 1998
  • This study is purposed to develop the sustained release and bioavailability of piracetam (PA). The use of alginate beads as a means to achieve sustained release of piracetam was evaluated in comparison with that of piracetam alone. In the PA-sodium alginate(SA) beads was confirmed by differential scanning calorimetry thermogram(DSC), indicating a relative shift of an endometric peak of PA to higher temperature. The changes in dissolution rates from PA-SA beads and PASA beads coated by chitosan(CHO) were significantly slower than that of intact PA. The release rate of PA-SA in the gastric fluid was markedly decreased compared with that in the intestinal fluid, suggesting that PA is mostly released in the intestinal fluid. However, the PA/SA ratio scarcely affected the release profile. The blood concentration- time curves of PA, PA-SA and PA-SA-CHO were obtained by oral administration to rats. $T_{max}$ of PA, PA-SA and PA-SA-CHO were 1, 10 and 6 hours, respectively. It was confirmed that the release of PA was prolonged by the formulation of PA-SA beads and PA-SA-CHO beads.

  • PDF

Preparation of Lacosamide Sustained-release Tablets and Their Pharmacokinetics in Beagles and Mini-pigs

  • Ahn, Jae Soon;Kim, Kang Min;Nam, Dae Sik;Kang, Kyoung Un;Choi, Peter S.;Jeong, Seo Young
    • Bulletin of the Korean Chemical Society
    • /
    • v.35 no.2
    • /
    • pp.557-561
    • /
    • 2014
  • The aim of the present study was to improve dosing of lacosamide, a functionalized amino acid used as an antiepileptic agent, from twice daily to once daily for the convenience of patients. A sustained-release lacosamide tablet was developed and dissolution testing was employed to determine in vitro release behavior using water or buffer solutions at pH 1.2, 4.0, or 6.8. Lacosamide was released for 12 h from the sustainedrelease (SR) tablet, as compared to complete release within 1 h from an immediate-release $Vimpat^{(R)}$ tablet. Each formulation (100 mg) was orally administered to six beagle dogs and six mini-pigs under fasted conditions, and pharmacokinetic parameters such as the area under the concentration time curve ($AUC_t$), the maximum plasma concentration ($C_{max}$), and the time at which this occurred ($T_{max}$) were calculated. These results showed similar values for $AUC_t$, $C_{max}$, and $T_{max}$ following oral administration of immediate-release ($Vimpat^{(R)}$) and SR lacosamide tablets.

Use of floating alginate beads for stomach drug delivery (부유특성을 갖는 알지네이트 비드를 이용한 위에서의 약물방출)

  • Song, Won-Hyun;Lee, Ki-Young
    • 한국생물공학회:학술대회논문집
    • /
    • 2002.04a
    • /
    • pp.139-144
    • /
    • 2002
  • Two types of alginate gel beads capable of floating in the gastric cavity were prepared. The first, alginate gell bead containing olive oil(Al-Oil), is a hydrogel bead and its buoyancy is attributable to olive oil held in the alginate gel matrix. The model drug, metronidazole(MZ), contained in Al-Oil was released gradually into artificial gastric fluid. The profiles of MZ release from Al-Oil shown initial burst and after 90 min they were about 100%. The second, alginate gel bead containing curdlan microsphere(Al-C), is a gel bead with curdlan-MZ microsphere in the matrix. To sustained release rate of drug, alginate bead were prepared curdlan microsphere containing MZ. Results demonstrated that sustained delivery of MZ over 2h can be easily achieved while the bead remained float. The release properties of prepared alginate beads are applicable not only for sustained release of drugs but also for targeting the gastric mucosa.

  • PDF

Rosin Microparticles as Drug Carriers: Influence of Various Solvents on the Formation of Particles and Sustained-release of Indomethacin

  • Lee Chang Moon;Lim Seung;Kim Gwang Yun;Kim Do Man;Kim Dong Woon;Lee Hyun Chul;Lee Ki Young
    • Biotechnology and Bioprocess Engineering:BBE
    • /
    • v.9 no.6
    • /
    • pp.476-481
    • /
    • 2004
  • The aim of this study was to formulate a sustained release system for indomethacin (IND) with rosin gum obtained from a pine tree. Rosin microparticles were prepared by a disper­sion and dialysis method without the addition of surfactant. In order to investigate the influence of solvents on the formation of colloidal microparitcles, various solvents like ethanol, DMF, DMAc, and acetone were used. The rosin microparticles containing IND were characterized by X­ray differactometry (XRD) and differential scanning calorimetry (DSC). The morphologies of rosin microparticles observed by scanning electron microscopy (SEM) were spherical. The solvents used to dissolve rosin significantly affected the drug content and drug release rate of IND. The release behaviors of IND from the rosin microparticles were dependent on the drug content and size of the particles. Rosin micorparticles with a higher drug content and of a larger particle size had a slower drug release rate. Also, the IND release rate from the rosin microparticles could be regulated by the rosin content in the microparticles. From these results, rosin microparticles have the potential of being used as a sustained release system of IND.

Effect of Particle Size of HPMC on Dissolution Rate of Venlafaxine HCl and Carbamazepine Sustained Release Tablet (HPMC의 입도에 따른 염산벤라팍신 및 카바마제핀 서방성 정제의 용출 특성)

  • Cha, Jae-Uk;Cha, Ja-Hyun;Hong, Jun-Kee;Lee, Sung-Wan;Ko, Won-Hwa;Beak, Hyun-Ho
    • Polymer(Korea)
    • /
    • v.36 no.3
    • /
    • pp.332-337
    • /
    • 2012
  • The primary objective of this work is to find the properties of sustained release dissolution pattern depending on solubility of drugs, so venlafaxine HCl and carbamazepine tablets were made by using polymer wich various particle size. Hydroxy propyl methyl cellulose (HPMC) has been utilized in this study as an excipient that is one of the most widely used polymers for an oral sustained release formulation, and drug release pattern was strongly influenced by swelling rate depending on particle size of HPMC. Scanning electron microscope (SEM) was employed to investigate the surface of tablets with various HPMC particle size, and differential scanning calorimeter (DSC) was employed to investigate the crystallization of drugs in tablets. The release model equation was applied to analyze the main mechanism of drug release pattern. The results demonstrate that drug release pattern is controlled by the drug solubility and HPMC particle size.

Development of Controlled Release Oral Drug Delivery System by Membrane-Coating Method-III- Preparation of Theophylline Tablets and Pharmacokinetic Evaluation in Man- (피막법에 의한 경구투여용 제어방출제제의 개발-III-테오필린함유 제어방출제제의 제조 및 사람의 타액중 농도로부터의 평가-)

  • Shim, Chang-Koo;Kim, Chong-Kook;Lee, Min-Hwa;Kim, Shin-Keun
    • Journal of Pharmaceutical Investigation
    • /
    • v.22 no.3
    • /
    • pp.205-210
    • /
    • 1992
  • In order to develop a controlled-release oral drug delivery system (DDS) of theophylline (TP), microporous membrane-coated tablets were prepared and evaluated in vitro and in vivo. Rapidly water-soluble core tablets of TP (300 mg) were prepared by wet granulation and compression technique, Then the core tablets were spray-coated with polyvinylchloride (PVC) in which micronized sucrose particles were dispersed. Effect of formula compositions of coating suspensions on the pharmaceutical characteristics such as membrane strength and dissolution was investigated in vitro. The membranes remained unbroken in pH 1.2 buffer at $37^{\circ}C$ at least for 2 hours after the disintergration test. TP was released from the coated-released tablets at a zero-order rate over 8 hours. The release at pH 1.2 and 4.0 was similar in rate but a little more rapid than that at pH 6.8. The coated tablets were administered to three healthy male volunteers and their saliva profiles of TP were compared with those from the commercial sustained release TP tablets such as Slobid and Asconthin. Saliva TP concentrations from the coated tablets were successfully sustained over 48 hours after the dosing and were comparable to those of the commercial sustained-release tablets. The membrane-coating technique is very simple and does not need any sophisticated equipments. In this respect, the membrane-coated tablets may be superior to the commercial sustained-release tablets and this technique is worth adopting by the pharmaceutical industries.

  • PDF

Pharmacokinetic Evaluation of Ketorolac Tromethamine Sustained-Release Pellets after Oral Administration in Rabbits (케토롤락트로메타민 서방성 펠렛의 약물속도론적 평가)

  • Kwak, Son-Hyok;Hwang, Sung-Joo;Jiang, Ge;Nam, Kyung-Wan;Moon, Young-Girl;Lee, Hai-Bang;Cho, Sun-Hang;Yuk, Soon-Hong;Lee, Han-Koo;Jeong, Sang-Young;Lee, Young-Won
    • Journal of Pharmaceutical Investigation
    • /
    • v.30 no.4
    • /
    • pp.241-246
    • /
    • 2000
  • To develop a sustained-release preparation containing ketorolac tromethamine, two sustained-release pellet formulations were evaluated with a pharmacokinetic study as compared with a conventional commercial tablets (10 mg $Tarasyn^{TM}$, Roche Korea Ltd.). Two sustained-release formulations were as follows; formulation A was composed of an inner layer containing 75% of drug coated with $Eudragit^{TM}$ RS 100 membrane and an outer layer containing 25% of drug mixed with $Eudragit^{TM}$ NE30D, and formulation B was composed of only an inner layer containing 100% of drug coated with $Eudragit^{TM}$ RS 100 membrane. The dissolution test was performed for two formulations. In case of conventional tablets, 2.5 mg of drug per a dose was administered orally into male Albino rabbit (2.0-2.3 kg of body weight) 3 times at intervals of 4 hours. In case of two sustained formulations, 7.5 mg of drug was administered once orally. Blood samples were withdrawn periodically after the administration, and the blood concentration was determined by HPLC. The conventional tablets showed very high peak-trough fluctuation between administered doses, but two sustained formulations showed less fluctuation. Formulation A with the loading dose showed the time to reach minimum effective concentration (MEC) i.e. the onset time was less than 20 min, while Formulation B had more than 1 hr of the onset time. Formulation A had the more constant plasma level than formulation B. However, formulation B had a time lag, so the plasma level was less than MEC for an initial period of 1 hr. In formulation A, the plasma level was maintained within the therapeutic window $(0.3-5\;{\mu}g/ml)$ for a long period. Formulation A was thought to be an ideal sustained-release formulation for ketorolac tromethamine oral delivery system.

  • PDF

Effects of Some Factors on the Preparation of Spherical Particles by Extrusion-Spheronization Processing (II) : Preparation of Sustained Release Matrix-Spherical Particle (압출(壓出).구형화공정(球形化工程)에 의(依)한 구형과입제조(球形顆粒製造)의 제형향인자(諸影響因子) 검토(檢討) [제이보(第二報)] -지속성구형과입제조-)

  • Lee, Kang-Choon;Min, Shin-Hong;Lee, Shang-Hi;Kim, Young-Bae
    • Journal of Pharmaceutical Investigation
    • /
    • v.5 no.1
    • /
    • pp.41-48
    • /
    • 1975
  • Extrusion-Spheronization Processing (ESP) was applied to preparate sustained release spherical particles as a form of matrix spherical particle (MSP). dl-methylephedrine HCI (ME) was the drug chosen and several dissolution retardants and binders were selected to estimate a relatively good formulation on this purpose. The effect of physicochemical nature, concentration, and solvents of these dissolution retardants and binders on regularity in shape of MSP and in vitro release rate was investigated. The effect of Particle size of matrix particles was also evaluated. It is, therefore, concluded that this ESP would be a relatively good preparation method of sustained release MSP of ME which has the sustained action of about 5 and 8 hours by formulating of ethylcellulose and ethylcellulose-paraffin as a dissolution retardant, respectively, and then ethylcellulose solution of 80% EtOH is recommended as a binder.

  • PDF

Physical Properties and Release Characterization of Sustained Release Lyogel Ointment (서방출성 리오겔 연고의 물리적성질과 방출특성)

  • Kim, Mi-Ok;Shin, Young-Hee;Kim, Dae-Duk;Lee, Chi-Ho
    • Journal of Pharmaceutical Investigation
    • /
    • v.28 no.1
    • /
    • pp.51-57
    • /
    • 1998
  • Tetracycline lyogel ointment consisting of hydroxy ethyl cellulose(HEC) in glycerin and Eudragit RS 100 in triacetin were prepared and then release characteristic were investigated. The physical properties of lyogel ointment such as viscosity, particle size and microscopic structures were also evaluated. The microscopic structures showed that lyogel particles containing drug were dispersed in the triactin solution. The release rate of drug from lyogel ointment as a function of HEC was not changed. However the release rate was significantly decresed when the amount of Eudragit RS 100 and triacetin in lyogel ointment was increased. The viscosity and weight fraction in external phase of lyogel ointment influenced the release rate. The current studies suggest that the release rate of drug can be controlled by changing of lyogel ointment compositions.

  • PDF

Release and Characterization of Multiple Coated Pellets Containing Melatonin (멜라토닌이 함유된 다층 코팅 펠렛의 방출 및 특성분석)

  • Kang, Bok-Ki;Khang, Gil-Son;Kim, Jong-Min;Jeung, Sang-Young;Lee, Hai-Bang;Cho, Sun-Hang
    • Journal of Pharmaceutical Investigation
    • /
    • v.33 no.3
    • /
    • pp.179-185
    • /
    • 2003
  • Melatonin (MT) is an indole amide pineal hormone. It has not only very short half-life but also pH-sensitive property. The sustained release dosage form which delivers MT in a circadian fashion over 8 h is clinical value. The purpose of this study is to prepare sugar beads using multiple coating methods and enteric-coated in a sustained release to evaluate in vitro release characteristics in simulated gastric and intestinal fluids. The $Eudragit^{\circledR}$ as a polymer, sustained release membrane, and triethylcitrate (TEC) as a plasticzer were used. Multi-coated melatonin delivery system was composed of sugar, various excipients, $Eudragit^{\circledR}$ and enteric materials (e.g. hydroxy propyl methyl cellulose phthalate, HPMCP), and prepared by fluid bed coater. The dissolution test was carried out using the basket method at a stirring speed of 100 rpm at $37^{\circ}C$ in simulated gastric (pH 1.2) and intestinal fluid (pH 7.4). The released amount of MT was determined by High performance liquid chromatography method. The morhologies of surface and cross section of multi-coated beads were observed by scanning electron microscope. Size of multi-coated sugar beads was ranged over $1000{\sim}1300\;{\mu}m$. The release rate of MT from coated beads was limited in simulated gastric fluid (pH 1.2), but it was sustained in intestinal fluid (pH 7.4) during $3{\sim}8$ hours. The MT beads may provide small-intestine-targeted device for oral delivery. Studies on animal and relative experiment are in process.